EUVIMEDEUVIMED entdecken
Crossref

Glucocorticoid excess disrupts NAD+ homeostasis in male and female mice

Samuel R Heaselgrave iD, Silke Heising, Minghao Deng, Stuart A Morgan, David M Carthwright, Christian Ludwig, Raissa N Rodrigues iD, Peter Aldiss, Jonas T Treebak iD, Kostas Tsintzas, Gareth G Lavery, Craig L Doig iD

Journal of Endocrinology · 01.05.2026 · 269 (2)

DOI: 10.1530/joe-26-0011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 11.05.2026. Verfasst von Samuel R Heaselgrave und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. Hauptthemen laut MEDLINE: NAD, Homeostasis, Glucocorticoids, Corticosterone. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid excess induces a plethora of metabolic disturbances, including obesity, muscle atrophy, hepatic steatosis and increased energy expenditure, which are hallmark features of Cushing’s syndrome. Despite the understanding of these outcomes, it remains unclear how glucocorticoid excess affects the metabolically critical nicotinamide adenine dinucleotide (NAD+) and related metabolites and transcripts, including redox cofactors, intermediates and biosynthetic enzymes. Furthermore, the therapeutic potential of NAD+ precursor supplementation in this context is unknown. Here, we investigated tissue- and sex-specific effects of sustained corticosterone treatment on NAD+ and its related metabolites and transcripts in skeletal muscle and liver of male and female mice and assessed the efficacy of nicotinamide riboside (NR) supplementation in preventing glucocorticoid-induced metabolic dysfunction. Using LC–MS and gene expression analyses, we demonstrate that glucocorticoid excess increases NAD+ and NAAD levels in skeletal muscle, alongside modest changes in salvage pathway gene expression in males and females. However, NADP+ was increased in males only. In the liver, glucocorticoid treatment decreased NADPH and increased the NADP+/NADPH ratio in males and females, with widespread downregulation of biosynthetic enzymes despite stable NAD+ levels. NR supplementation failed to prevent classical features of glucocorticoid excess, including increased body weight, muscle atrophy, adiposity, hepatic triglyceride accumulation and elevated energy expenditure. These findings not only reveal novel effects of glucocorticoid excess on NAD+ and related metabolites and transcripts but also question the importance of NAD+ in glucocorticoid-induced metabolic dysfunction. Consequently, whilst NAD+ pathways are impacted by glucocorticoid excess, our data show no therapeutic benefit of NR supplementation under the conditions tested and do not support its efficacy in this model of glucocorticoid excess.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NADHomeostasisGlucocorticoidsCorticosteroneAnimalsMaleFemaleMiceMuscle, SkeletalLiverNiacinamideEnergy MetabolismMice, Inbred C57BLNADPPyridinium Compounds

Stichwörter der Autor:innen

de novo biosynthesisglucocorticoid excessnicotinamide adenine dinucleotidenicotinamide riboside

Substanzen

NADGlucocorticoidsCorticosteroneNiacinamidenicotinamide-beta-ribosideNADPPyridinium Compounds

Autor:innen und Institutionen

  • Center of Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
  • Centre for Systems Health and Integrated Metabolic Research, Department of Biosciences, Nottingham Trent University, Nottingham, UK.
  • Metabolism and Systems Sciences, School of Medical Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Nottingham Digestive Diseases Centre, Translational Medical Sciences, and The Biodiscovery Institute, University of Nottingham, Nottingham, UK.
  • MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

ORCID-Profile: Samuel R Heaselgrave, Raissa N Rodrigues, Jonas T Treebak, Craig L Doig

Zitieren

APA

Heaselgrave, S. R., Heising, S., Deng, M., Morgan, S. A., Carthwright, D. M., Ludwig, C., Rodrigues, R. N., Aldiss, P., Treebak, J. T., Tsintzas, K., Lavery, G. G., & Doig, C. L. (2026). Glucocorticoid excess disrupts NAD+ homeostasis in male and female mice. Journal of Endocrinology, 269(2). https://doi.org/10.1530/joe-26-0011

Vancouver

Heaselgrave SR, Heising S, Deng M, Morgan SA, Carthwright DM, Ludwig C, et al. Glucocorticoid excess disrupts NAD+ homeostasis in male and female mice. Journal of Endocrinology. 2026;269(2). doi:10.1530/joe-26-0011

BibTeX
@article{Heaselgrave2026,
  author = {Heaselgrave, Samuel R and Heising, Silke and Deng, Minghao and Morgan, Stuart A and Carthwright, David M and Ludwig, Christian and Rodrigues, Raissa N and Aldiss, Peter and Treebak, Jonas T and Tsintzas, Kostas and Lavery, Gareth G and Doig, Craig L},
  title = {Glucocorticoid excess disrupts NAD+ homeostasis in male and female mice},
  journal = {Journal of Endocrinology},
  year = {2026},
  volume = {269},
  number = {2},
  doi = {10.1530/joe-26-0011}
}
Kostenlos starten →